Opioid induced constipation (oic) treatment market by Monica

Opioid-Induced Constipation (OIC) Treatment Market Volume Forecast and Value Chain Analysis 2016-2026 November 2016

About Future Market Insights Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client.

Research Capabilities    

Customized Research Syndicated Research Investment Research

Social Media Research

Customized Research Syndicated Research Investment Research Social Media Research

Sector Coverage    

Automotive and Transportation Electronics, Semiconductor, and ICT Retail and Consumer Products Industrial Automation and Equipment

   

Chemicals & Materials Food and Beverages Services and Utilities Energy, Mining, Oil, and Gas

Subscription Information

For detailed subscription information please contact Hari. T (Sr. Manager - Global Business Development) T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com

Research Methodology (1/2) Systematic Research Approach 1 Market profiling

2 Formulating discussion guide

3 Developing list of respondents

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc. PMR formulates a detailed discussion guide to conduct expert and industry interviews PMR develops a list of industry players (manufacturers), distributors, retailers and industry experts

Data collection

PMR conducts interviews with industry experts, industry players, distributors and retailers

Data validation

Data is validated by triangulation method, wherein secondary, primary and PMR analysis contribute to the final data

5 6

Data analysis

Insights

Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry PMR delivers industry insights and information in the required format (PDF)

Data Collection

   

Research & Intelligence

Data Filter & Analysis

Identifying key opinion leaders Questionnaire design In-depth interviews Coverage across value chain

Actionable Insights

A Primary Research

     

B SOLUTION     

Market participants Key strengths Product portfolio Mapping as per value chain Key focus segments

Primary Research #    

Linkedin Zoominfo Salesforce Avention

Business Solution

Desk Research

Key industry experts Channel study Developments Market dynamics Products Conclusions

Company Analysis

Secondary Research #    

Company websites Company annual reports White papers Financial reports

Paid Publications#    

Factiva GBI Genios Meltwater

# includes sources of databases

Global Opioid-Induced Constipation (OIC) Treatment Market Opioids are a class of medications that are regularly endorsed for their pain relieving, or pain-killing, properties it is chronic and non-cancer pain. A typical symptom connected with the utilization of these medications are that they decrease the gastrointestinal tract's motility, making solid discharges and making patients strain. In addition, prolonged utilization of opioids can prompt the harm of sensory system that causes body cells to quit creating endogenous opioids, for example, endorphins. There is high risk of constipation in adults since they have poor diet, poor fluid intake and immobility. The typical symptoms for opioid-induced constipation are feeling lethargic, hard and dry stools, distention and bulged abdomen, painful defecation and loss of appetite. The opioid-induced constipation (OIC) treatment market is an exceptionally alluring and promising market because of the expanding base of opioid-induced constipation OIC sufferers. Opioid-Induced Constipation (OIC) Treatment Market: Drivers and Restraints Raising base of the illegal medication users and delayed utilization of opioids in the treatment of chronic pain are the essential elements energizing the development of the opioid- induced constipation (OIC) treatment business sector. In addition, expanded mindfulness among patients and doctors for utilizing nonpurgative medicine choices to treat opioid induced constipation would promote drive the development of the OIC treatment market sooner rather than later. In addition, it has been assessed that the undiscovered market for successful, advantageous and safe medication treatment in OIC drug is profoundly broad and developing. However, lack of awareness about opioid-induced constipation in patients, absence of mindfulness with respect to the forthcoming treatment innovation, high costs of novel pharmaceuticals and unfavorable reimbursement guidelines by medical coverage organizations are probably the most prevailing limit for the opioid- induced constipation treatment market. ÂŠ2015 Future Market Insights, All Rights Reserved

Global Opioid-Induced Constipation (OIC) Treatment Market Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1245 Opioid-Induced Constipation (OIC) Treatment Market: Overview With expanding base of opioid-induced constipation (OIC) sufferers, the opioid-induced constipation (OIC) treatment market is expected to have tremendous growth during the forecast period (2016-2026). The latest trend in the opioid-induced constipation market is development of novel and effective treatment technology by incurring nominal expenses in research and development (R&D). Introducing convenient dosing, peripherally restricted μ-opioid receptor antagonist (PAMORA) target main cause of opioid- induced constipation (OIC) thiswill drive the opioid- induced constipation (OIC) treatment market. Opioid-Induced Constipation (OIC) Treatment Market: Segmentation Globalopioid-induced constipation (OIC)marketis segmented on the basis of active ingredients, administration of drugs, drug class, distribution channel and geography as following:  Segmentation by Active Ingredients 

Naloxegol



Lubiprostone



Global Opioid-Induced Constipation (OIC) Treatment Market 

Docusate Sodium



Others (Osmotic laxatives, Emollient or lubricant cathartics, Bulk cathartics, Stimulant cathartics, Prostaglandins or prokinetic drugs)

 Segmentation by method of administration 

Oral



Parenteral (Subcutaneous Injection)

 Segmentation by drug class 

Peripherally-Restricted μ-opioid Receptor Antagonist (PAMORA)



Non-selective opioid antagonist



μ-Opioid antagonist



Locally Acting Chloride Channel Activator (LACCA)

 Segmentation by Distribution Channel 

Drug store



Independent Pharmacies



Click here to Order a free sample 6

Global Opioid-Induced Constipation (OIC) Treatment Market Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1245 Opioid-Induced Constipation (OIC) Treatment Market: Region- wise Outlook North America is the main market for opioid induced constipation treatment because of the expanding base of OIC sufferers and illegal medication users. It is then followed by Europe because of high incidence of opioid-induced constipation OIC for chronic pain. Besides that, Latin America and South East-Asia area are some of potential areas where presentation of successful opioid-induced constipation treatments may help up the general income of a specific pharmaceutical organization, because of the expanding base of OIC sufferers. The high development of the opioid-induced constipation market is credited to the strong government motivation in healthcare sector likewise with the vicinity of an extensive pool of patients suffering from chronic pain Opioid-Induced Constipation (OIC) Treatment Market: Key Players Key Players operating in this segment are GlaxoSmithKline, Inc., AstraZeneca plc, Inc., Pfizer, Inc., S.L.A. Pharma AG, AIKO Biotechnology, Cubist Pharmaceuticals, Salix Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited Browse Full Report@ http://www.futuremarketinsights.com/reports/opioid-Induced-constipation-oictreatment-market ÂŠ2015 Future Market Insights, All Rights Reserved

To know more about us, please visit our website:

www.futuremarketinsights.com For sales queries or new topics email us on:

sales@futuremarketinsights.com For media queries, contact the press office at press@futuremarketinsights.com For other queries contact: Hari. T (Sr. Manager - Global Business Development) Future Market Insights: 3rd Floor, 207 Regent Street, London W1B 3HH T: +44 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com

Thank You Future Market Insights Global & Consulting Private Limited (FMI)